Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
announced today that Kenneth C. Frazier, chairman and chief executive
officer; Adam H. Schechter, executive vice president and president,
Global Human Health; and Dr. Roy Baynes, senior vice president, Clinical
Development, Merck Research Laboratories, are scheduled to participate
at the Morgan Stanley Global Healthcare Conference in New York on Sept.
9, 2014 at 8:00 a.m. EDT.
Language:
English
Contact:
MerckMedia:Lainie Keller, 308-423-4187orInvestors:Justin Holko, 908-423-5088
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more